Scarica l'app Stockscreener
0.00
100.00%
-18.11
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GRTX Giù?
Forum
Previsione
Galera Therapeutics Inc Borsa (GRTX) Ultime notizie
Obsidian Therapeutics: A $1.1 Billion Valuation Leaves Little Margin For Error (OBX) - Seeking Alpha
Obsidian Therapeutics, Inc. SEC Filing (Sep 10, 2026) - Stock Titan
Obsidian Therapeutics initiated with an Outperform at William Blair - TipRanks
Galera Therapeutics Inc. (GRTX) Peer Comparison – Compare with Others - Value Research
[S-1] Obsidian Therapeutics, Inc. Files IPO Registration Statement - Stock Titan
Obsidian Therapeutics Merges with Galera Therapeutics - Labroots
Ikarian Capital (GRTX) reports 0% beneficial ownership of Galera Therapeutics in 13G/A amendment - Stock Titan
Obsidian Therapeutics (OBX) boosts cash with $350M PIPE and Galera merger - Stock Titan
Obsidian Therapeutics (OBX) outlines $350M PIPE, Galera mergers and CVR structure - Stock Titan
Obsidian Therapeutics (OBX) CFO Julie Feder reports stock options on 3.0M shares - Stock Titan
OBX SEC FilingsObsidian Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Obsidian Therapeutics (OBX): RA Capital discloses 5.96M-share, 9.7% position - Stock Titan
Galera Therapeutics, Inc. SEC Filing (Aug 10, 2026) - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Galera Therapeutics (GRTX) CEO reports option and share disposition tied to merger - Stock Titan
Galera Therapeutics, Inc. (GRTX) details director option change - Stock Titan
Galera Therapeutics (NASDAQ: GRTX) details conversions tied to Obsidian merger - stocktitan.net
Galera Therapeutics (NASDAQ: GRTX) director’s options converted in merger - Stock Titan
Galera Therapeutics (GRTX) CAO exits 10,000 stock options in merger - Stock Titan
Galera Therapeutics (GRTX) director details merger-driven stock and option moves - stocktitan.net
Obsidian Therapeutics’ Nasdaq Listing via Galera Reverse Merger Yields 170% Gain to RTW Bio’s Valuation - Kalkine Media
Galera Therapeutics, Inc. SEC Filing (Aug 4, 2026) - Stock Titan
GALERA THERAPEUTICS, INC : PIPER SANDLER INITIATES COVERAGE WITH OVERWEIGHT RATING; PRICE TARGET $42 - Bitget
Obsidian Therapeutics Completes Merger and Leadership Transition - TipRanks
Galera Therapeutics Completes Merger with Obsidian Therapeutics and Becomes Obsidian Therapeutics, Inc - Minichart
Galera Therapeutics, Inc. Announces Resignation of Joel Sussman as the Principal Financial and Accounting Officer - marketscreener.com
Galera (NASDAQ: GRTX) closes Obsidian merger, sets 80%/95% CVRs - Stock Titan
Galera Therapeutics, Inc. (GRTXD) Latest Press Releases & Corporate News - Yahoo! Finance Canada
Obsidian Completes Galera Merger with $350M Private Placement Financing - Contract Pharma
Obsidian Therapeutics completes merger with Galera By Investing.com - Investing.com Nigeria
Obsidian Therapeutics Completes Galera Merger and $350 Million Financing - citybiz
Obsidian Therapeutics completes merger with Galera - Investing.com
Galera Therapeutics Announces Major PIPE Financing and CVRs - tipranks.com
Galera Therapeutics (NASDAQ: GRTX) raises $350M PIPE, issues CVRs before merger - Stock Titan
Galera Therapeutics, Inc. (GRTXD) Stock Price, News, Quote & History - Yahoo Finance
GRTXD Interactive Stock Chart | Galera Therapeutics, Inc. Stock - Yahoo Finance
Galera Therapeutics, Inc. (GRTXD) insider ownership and holdings - Yahoo Finance Singapore
Galera Therapeutics, Inc. (GRTXD) - Yahoo! Finance Canada
Galera Therapeutics, Inc. (GRTXD) Company Profile & Facts - Yahoo! Finance Canada
Galera Therapeutics, Inc. (GRTXD) Stock Major Holders - Yahoo! Finance Canada
Galera Therapeutics, Inc. (GRTXD) Stock Forum & Discussion - Yahoo! Finance Canada
GRTXD: Galera TherapeuticsInsider Transations - Zacks Investment Research
Galera Therapeutics (GRTXD) Pe Ratio (TTM) - Zacks Investment Research
Gross profit of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView
Cost of goods sold of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView
All News for GRTXD : Galera Therapeutics - Zacks Investment Research
Cash flow from financing activities of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView
Cash flow from investing activities of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView
Free cash flow of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView
Operating income of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView
Non-controlling/minority interest of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView
Average basic shares outstanding of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView
Timothy Opler Net Worth (2026) - GuruFocus
Net debt of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView
Total liabilities & shareholders' equities of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView
After tax other income/expense of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView
Total liabilities of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView
Total debt of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView
Galera Therapeutics, Inc. Cash Flow – OTC:GRTXD - TradingView
Galera Therapeutics, Inc. Balance Sheet – OTC:GRTXD - TradingView
Total revenue of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView
EBIT of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView
Galera Therapeutics (GRTXD) Stock Forum and Discussion - Moomoo
Pretax income of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView
Discontinued operations of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView
Dilution adjustment of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView
Operating expenses (excl. COGS) of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView
Total operating expenses of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView
Diluted earnings per share (diluted EPS) of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView
Enterprise value of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView
0.79%
Capitalizzazione:
|
Volume (24 ore):